What they found: In normal obese mice: AOD-9604 reduced body fat by 21 % vs placebo, hGH by 24 % The AOD-9604 effect was fully dependent on the 3-adrenergic receptor , in knock-out mice no effect The hGH effect was partly independent of 3-AR , in knock-out mice there was still ~10 % fat reduction AOD-9604 did not raise IGF-1 (control level), whereas hGH raised IGF-1 by 80 % No changes in growth, organ weights (except adipose tissue), fasting insulin Why it matters: The study provided the mechanistic basis for AOD-9604 and confirmed the key business hypothesis: it is possible to separate the lipolytic effect of GH from its growth effect
"Micronutrient deficits are still public health issues among women and young children in Vietnam"
Dosage: 200-500 mcg, 1-2 times daily via subcutaneous injection or daily oral capsules
When You Should See a Specialist Or Stop Treatment If a clinician suspects a true allergic reaction, they may recommend stopping tirzepatide and referring to an allergist for testing, or initiating short-course corticosteroids or other targeted treatments
Accessed November 4, 2024
Administration Guidelines BPC-157 comes as lyophilized powder requiring reconstitution with bacteriostatic water
